An inflammation-centric view of neurological disease: beyond the neuron

SD Skaper, L Facci, M Zusso, P Giusti - Frontiers in cellular …, 2018 - frontiersin.org
Inflammation is a complex biological response fundamental to how the body deals with
injury and infection to eliminate the initial cause of cell injury and effect repair. Unlike a …

Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management

A Pardanani - American journal of hematology, 2019 - Wiley Online Library
Overview Systemic mastocytosis (SM) results from a clonal proliferation of abnormal mast
cells (MCs) in extra‐cutaneous organs. Diagnosis The major criterion is presence of …

Mast cells in neuroinflammation and brain disorders

E Hendriksen, D van Bergeijk, RS Oosting… - Neuroscience & …, 2017 - Elsevier
It is well recognized that neuroinflammation is involved in the pathogenesis of various
neurodegenerative diseases. Microglia and astrocytes are major pathogenic components …

Mast cells on the mind: new insights and opportunities

R Silver, JP Curley - Trends in neurosciences, 2013 - cell.com
Mast cells (MCs) are both sensors and effectors in communication among nervous, vascular,
and immune systems. In the brain, they reside on the brain side of the blood–brain barrier …

Neuroinflammation, microglia and mast cells in the pathophysiology of neurocognitive disorders: a review

SD Skaper, L Facci, P Giusti - CNS & Neurological Disorders …, 2014 - ingentaconnect.com
Cells of the immune system and the central nervous system are capable of interacting with
each other. The former cell populations respond to infection, tissue injury and trauma by …

Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management

A Pardanani - American journal of hematology, 2016 - Wiley Online Library
Disease overview: Systemic mastocytosis (SM) results from a clonal proliferation of
abnormal mast cells (MC) in one or more extra‐cutaneous organs. Diagnosis: The major …

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study

O Lortholary, MO Chandesris, CB Livideanu, C Paul… - The Lancet, 2017 - thelancet.com
Background Indolent systemic mastocytosis, including the subvariant of smouldering
systemic mastocytosis, is a lifelong condition associated with reduced quality of life …

[HTML][HTML] Hyper/neuroinflammation in COVID-19 and suicide etiopathogenesis: Hypothesis for a nefarious collision?

A Costanza, A Amerio, A Aguglia, G Serafini… - Neuroscience & …, 2022 - Elsevier
Accumulating scientific and clinical evidence highlighted pathological hyperinflammation as
a cardinal feature of SARS-CoV-2 infection and acute COVID-19 disease. With the …

Gender disparity in prevalence of depression among patient population: a systematic review

KH Abate - Ethiopian journal of health sciences, 2013 - ajol.info
Background: Many people are unable to withstand the set point for usual vicissitudes of life
and are overwhelmed by depression, especially when there is a potential stressor like a …

Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis

S Georgin-Lavialle, DS Moura, A Salvador… - Molecular …, 2016 - nature.com
Converging sources of evidence point to a role for inflammation in the development of
depression, fatigue and cognitive dysfunction. More precisely, the tryptophan (TRP) …